Synthesis, characterization, and in vivo efficacy of shell cross-linked nanoparticle formulations carrying silver antimicrobials as aerosolized therapeutics.
about
Polymeric Nanostructures for Imaging and TherapyPreparation and in vitro antimicrobial activity of silver-bearing degradable polymeric nanoparticles of polyphosphoester-block-poly(L-lactide).Investigating the pharmacokinetics and biological distribution of silver-loaded polyphosphoester-based nanoparticles using (111) Ag as a radiotracer.Surface charges and shell crosslinks each play significant roles in mediating degradation, biofouling, cytotoxicity and immunotoxicity for polyphosphoester-based nanoparticles.Benzyl-substituted metallocarbene antibiotics and anticancer drugs.Folic acid conjugated and Ag-carrying organoclay nanoparticles and their response to L929 fibroblast and DLD-1 cancer cells.Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.17β-estradiol dysregulates innate immune responses to Pseudomonas aeruginosa respiratory infection and is modulated by estrogen receptor antagonism.Degradable polyphosphoester-based silver-loaded nanoparticles as therapeutics for bacterial lung infections.Antimicrobial Activity of Ibuprofen Against Cystic Fibrosis Associated Gram-Negative Pathogens.A novel in vitro metric predicts in vivo efficacy of inhaled silver-based antimicrobials in a murine Pseudomonas aeruginosa pneumonia model.
P2860
Q30372383-8C5DDBA9-335B-48EC-ADC2-19A615EB291BQ35684310-DD38BF57-943C-44C6-81E8-8C311977D325Q35688572-9F132C74-30F1-46AA-A967-9114D095F55CQ37334228-95DE271C-8563-49C7-9ED2-21DF6F4D690DQ38207472-14863313-0539-4EAC-A4C4-5945F9214634Q38728299-9AC4F38D-2478-4A44-89FD-D5C210FE7229Q38789348-26DC7D49-E4A9-4711-A2BA-3C717155166AQ40103064-970FA35C-516B-4095-8855-77535FF4A8F6Q41554387-9DC5029C-B7B3-48B3-A1E9-56A5CC665D51Q50134125-EF136AB0-A83C-4959-9047-5EA9D9A94031Q52568549-114C4383-3572-4C5B-A7D4-9B4EEEC65D55
P2860
Synthesis, characterization, and in vivo efficacy of shell cross-linked nanoparticle formulations carrying silver antimicrobials as aerosolized therapeutics.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Synthesis, characterization, a ...... s as aerosolized therapeutics.
@ast
Synthesis, characterization, a ...... s as aerosolized therapeutics.
@en
Synthesis, characterization, a ...... s as aerosolized therapeutics.
@nl
type
label
Synthesis, characterization, a ...... s as aerosolized therapeutics.
@ast
Synthesis, characterization, a ...... s as aerosolized therapeutics.
@en
Synthesis, characterization, a ...... s as aerosolized therapeutics.
@nl
prefLabel
Synthesis, characterization, a ...... s as aerosolized therapeutics.
@ast
Synthesis, characterization, a ...... s as aerosolized therapeutics.
@en
Synthesis, characterization, a ...... s as aerosolized therapeutics.
@nl
P2093
P2860
P356
P1433
P1476
Synthesis, characterization, a ...... s as aerosolized therapeutics.
@en
P2093
Brian D Wright
Carolyn L Cannon
Daniel S Han
Fuwu Zhang
Gyu Seong Heo
Jasur A Tagaev
Justin A Smolen
Lily Yun Lin
Matthew J Panzner
Parth N Shah
P2860
P304
P356
10.1021/NN400322F
P407
P577
2013-06-04T00:00:00Z